ISPOR 2026

Tempus is a technology company advancing outcomes research and real-world evidence generation with artificial intelligence.

Schedule a meeting with us

AI-enabled technologies
Research highlights

AI-enabled technologies

May 18, 2026 - May 20, 2026

Location
Booth #1010

Exhibit Hall Hours
Monday, May 18: 9:30am–7:00pm
Tuesday, May 19: 9:30am–7:00pm
Wednesday, May 20: 8:30am–11:30am

Tempus AI & Technology

Stop by our booth to discover how Tempus is deploying artificial intelligence to advance HEOR.

Tempus Lens

Quickly find, access, and analyze multimodal de-identified data records and uncover critical insights to accelerate research and innovation. Leverage our Al assistant, Tempus One, to quickly define detailed patient cohorts using natural language processing and transform complex criteria into actionable datasets in seconds. Explore unstructured clinical data and extract nuanced insights.

Research highlights

May 19, 2026

Time
10:30am–1:30pm ET

Location
Poster Number: RWD92

Presenters
Zach Rivers, PharmD, PhD (Tempus AI, Inc.),
et al.

Poster Number
RWD92

Portability of performance status calculations in real-world cancer care

This study explored the external validity of the Disability Score (DS), a measure developed to ascertain patient performance status (PS) when it is missing from real-world data. Using Tempus AI records and claims data, the study analyzed a cohort of 5,784 patients with metastatic breast, colorectal, and non-small cell lung cancer. While the DS model showed high sensitivity and accuracy, it had consistently low specificity, indicating that it overclassified patients with good PS. The study concludes that the DS measure was not externally valid in these real-world cohorts, highlighting the need for future PS imputation models to leverage datasets that more closely align with the target population.

Schedule a meeting with us

We'll be in touch shortly.